Related Experiment Video
Updated: Oct 15, 2025

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29-35 Weeks' Gestation
Thivia Jegathesan1,2, Joel G Ray1,3,4, Vinod K Bhutani5
1Institute of Medical Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Insights
This study establishes hour-specific total serum bilirubin (TSB) percentile cut-points for preterm infants, aiding in hyperbilirubinemia monitoring. These novel nomograms provide crucial data for clinical decision-making in neonatal care.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
Background:
- Preterm infants are highly susceptible to hyperbilirubinemia, necessitating vigilant monitoring.
- Current clinical practice lacks established hour-specific total serum bilirubin (TSB) percentile cut-points for preterm neonates.
- This deficiency hinders timely and accurate assessment of hyperbilirubinemia risk prior to phototherapy initiation.
Purpose of the Study:
- To develop and present hour-specific TSB percentile nomograms for preterm infants.
- To provide a data-driven tool for describing bilirubin levels in relation to gestational age and postnatal age.
- To inform clinical management and research regarding hyperbilirubinemia in this vulnerable population.
Main Methods:
- A retrospective cohort study was conducted involving 2,549 preterm infants (290/7-356/7 weeks' gestation) across three NICUs in Ontario, Canada.
- Data from 6,143 pre-treatment TSB levels were collected between January 2013 and June 2017.
- Hour-specific TSB percentiles were generated using quantile regression, stratified by gestational age and phototherapy status.
Main Results:
- Hour-specific TSB percentiles at birth, 75th, and 95th were established for the overall cohort.
- Distinct percentile values were reported for infants who received phototherapy versus those who did not.
- Significant differences in TSB percentiles were observed based on degree of prematurity (29-32 weeks vs. 33-35 weeks' gestation).
Conclusions:
- The developed hour-specific TSB percentile nomograms offer a novel method for characterizing bilirubin levels in preterm newborns.
- These nomograms may assist in the standardized description and interpretation of TSB levels.
- Further research is warranted to validate and integrate these pre-treatment TSB level findings into routine clinical practice.
Introduction:
As preterm infants are susceptible to hyperbilirubinemia, they require frequent close monitoring. Prior to initiation of phototherapy, hour-specific total serum bilirubin (TSB) percentile cut-points are lacking in these infants, which led to the current study.
Methods:
A multi-site retrospective cohort study of preterm infants born between January 2013 and June 2017 was completed at 3 NICUs in Ontario, Canada. A total of 2,549 infants born at 290/7-356/7 weeks' gestation contributed 6,143 pre-treatment TSB levels. Hour-specific TSB percentiles were generated using quantile regression, further described by degree of prematurity, and among those who subsequently received phototherapy.
Results:
Among all infants, at birth, hour-specific pre-treatment, TSB percentiles were 36.1 µmol/L (95% confidence interval [CI]: 34.3-39.3) at the 40th, 52.3 µmol/L (49.4-55.1) at the 75th, and 79.5 µmol/L (72.1-89.6) at the 95th percentiles. The corresponding percentiles were 39.3 μmol/L (35.9-43.2), 55.4 μmol/L (52.1-60.2), and 87.1 μmol/L (CI 70.5-102.4) prior to initiating phototherapy and 24.4 μmol/L (20.4-28.8), 35.3 μmol/L (31.1-41.5), and 52.0 μmol/L (46.1-62.4) among those who did not receive phototherapy. Among infants born at 29-32 weeks, pre-treatment TSB percentiles were 53.9 µmol/L (49.4-61.0) and 95.5 µmol/L (77.5-105.0) at the 75th and 95th percentiles, with respective values of 48.7 µmol/L (43.0-52.3), and 74.1 µmol/L (64.8-83.2) for those born at 33-35 weeks' gestation.
Conclusion:
Hour-specific TSB percentiles, derived from a novel nomogram, may inform how bilirubin is described in preterm newborns. Further research of pre-treatment TSB levels is required before clinical consideration.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Quartile
1; 1; 2; 2; 4; 6; 6.8; 7.2; 8; 8.3; 9; 10; 10; 11.5
The median or second quartile is seven. The lower half of the...
Serum Studies: Renal Function Tests

